Enanta Pharmaceuticals
ENTA
#8713
Rank
S$0.29 B
Marketcap
S$10.29
Share price
-3.04%
Change (1 day)
-35.02%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - P/B ratio

P/B ratio as of November 2026 : 2.30

According to Enanta Pharmaceuticals 's latest financial reports the company has a price-to-book ratio of 3.56157.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Enanta Pharmaceuticals - P/B ratio (from 2013 to 2026)

P/B ratio by year

Year P/B ratio Change
2026-12-31N/A-100%
2025-12-313.29188.61%
2024-12-311.1410.31%
2023-12-311.03-67.89%
2022-12-313.22-19.38%
2021-12-313.99113.3%
2020-12-311.87-26.3%
2019-12-312.54-21.32%
2018-12-313.23-8.74%
2017-12-313.5348.58%
2016-12-312.381.29%
2015-12-312.35-51.94%
2014-12-314.895.25%
2013-12-314.64
2012-12-31N/A
2011-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Johnson & Johnson
JNJ
7.89 243.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
7.60 230.61%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
-85.1-3,801.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
6.52 183.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
7.80 239.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
5.10 121.57%๐Ÿ‡บ๐Ÿ‡ธ USA